Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Knudsen, Erik S.
2299  Ergebnisse:
Personensuche X
?
1

The Extracellular Niche and Tumor Microenvironment Enhance ..:

Kumarasamy, Vishnu ; Wang, Jianxin ; Frangou, Costakis...
Cancer Research.  84 (2024)  7 - p. 1115-1132 , 2024
Link: https://doi.org/10.1158/..
 
?
2

Real-World Experience among Elderly Metastatic Breast Cance..:

O'Connor, Thomas N. ; Schultz, Emily ; Wang, Jianxin...
Cancers.  16 (2024)  9 - p. 1749 , 2024
Link: https://doi.org/10.3390/..
 
?
3

Cancer takes many paths through G1/S:

Knudsen, Erik S. ; Witkiewicz, Agnieszka K. ; Rubin, Seth M.
Trends in Cell Biology.  , 2023
Link: https://doi.org/10.1016/..
 
?
4

The BET inhibitor/degrader ARV-825 prolongs the growth arre..:

Finnegan, Ryan M. ; Elshazly, Ahmed M. ; Patel, Nipa H....
Frontiers in Oncology.  12 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

PROTAC-mediated CDK degradation differentially impacts canc..:

Kumarasamy, Vishnu ; Gao, Zhe ; Zhao, Bosheng...
British Journal of Cancer.  129 (2023)  8 - p. 1238-1250 , 2023
Link: https://doi.org/10.1038/..
 
?
6

Determinants of response to CDK4/6 inhibitors in the real-w..:

Witkiewicz, Agnieszka K. ; Schultz, Emily ; Wang, Jianxin...
npj Precision Oncology.  7 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of..:

Hamad, Samera H. ; Montgomery, Stephanie A. ; Simon, Jeremy M....
Oncogene.  41 (2022)  25 - p. 3423-3432 , 2022
Link: https://doi.org/10.1038/..
 
?
8

Real-World Experience with CDK4/6 Inhibitors for Metastatic..:

Knudsen, Erik S ; Schultz, Emily ; Hamilton, Deanna...
The Oncologist.  27 (2022)  8 - p. 646-654 , 2022
Link: https://doi.org/10.1093/..
 
?
9

RB loss determines selective resistance and novel vulnerabi..:

Kumarasamy, Vishnu ; Nambiar, Ram ; Wang, Jianxin...
Oncogene.  , 2022
Link: https://doi.org/10.1038/..
 
?
10

CDK/cyclin dependencies define extreme cancer cell-cycle he..:

Knudsen, Erik S. ; Kumarasamy, Vishnu ; Nambiar, Ram...
Cell Reports.  38 (2022)  9 - p. 110448 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the ..:

Hamad, Samera H. ; Montgomery, Stephanie A. ; Simon, Jeremy M....
Oncogene.  41 (2022)  39 - p. 4485-4485 , 2022
Link: https://doi.org/10.1038/..
 
?
12

A Phase I Study of Ribociclib Plus Everolimus in Patients w..:

Weinberg, Benjamin A. ; Wang, Hongkun ; Witkiewicz, Agnieszka K....
Journal of Pancreatic Cancer.  6 (2020)  1 - p. 45-54 , 2020
Link: https://doi.org/10.1089/..
 
?
13

Metabolic Reprogramming of Pancreatic Cancer Mediated by CD..:

Franco, Jorge ; Balaji, Uthra ; Freinkman, Elizaveta..
Cell Reports.  32 (2020)  1 - p. 107793 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Pan-cancer molecular analysis of the RB tumor suppressor pa..:

Knudsen, Erik S. ; Nambiar, Ram ; Rosario, Spencer R....
Communications Biology.  3 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
15

Cell cycle plasticity driven by MTOR signaling: integral re..:

Knudsen, Erik S. ; Kumarasamy, Vishnu ; Ruiz, Amanda...
Oncogene.  38 (2019)  18 - p. 3355-3370 , 2019
Link: https://doi.org/10.1038/..
 
1-15